<SEC-DOCUMENT>0001683168-25-006042.txt : 20250813
<SEC-HEADER>0001683168-25-006042.hdr.sgml : 20250813
<ACCEPTANCE-DATETIME>20250813161534
ACCESSION NUMBER:		0001683168-25-006042
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250813
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250813
DATE AS OF CHANGE:		20250813

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AETHLON MEDICAL INC
		CENTRAL INDEX KEY:			0000882291
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				133632859
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37487
		FILM NUMBER:		251211832

	BUSINESS ADDRESS:	
		STREET 1:		11555 SORRENTO VALLEY ROAD, SUITE 203
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		619-941-0360

	MAIL ADDRESS:	
		STREET 1:		11555 SORRENTO VALLEY ROAD, SUITE 203
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BISHOP EQUITIES INC
		DATE OF NAME CHANGE:	19930602
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>aemd_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:AEMD="http://aethlonmedical.com/20250813">
<head>
     <title>AETHLON MEDICAL, INC. 8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_AEMD_aethlonmedical.com_20250813 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20250813_20250813 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05F_edei%2D%2DEntityCentralIndexKey_0000882291 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-08-13" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-08-13" id="Fact000004" name="dei:EntityCentralIndexKey">0000882291</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="aemd-20250813.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-08-13">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000882291</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-13</xbrli:startDate>
        <xbrli:endDate>2025-08-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 12pt"><b>FORM <span id="xdx_903_edei--DocumentType_c20250813__20250813_zgnQcjVVlcT"><ix:nonNumeric contextRef="AsOf2025-08-13" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<b><span id="xdx_909_edei--DocumentPeriodEndDate_c20250813__20250813_zkXVlKDC3sq8"><ix:nonNumeric contextRef="AsOf2025-08-13" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">August 13, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_904_edei--EntityRegistrantName_c20250813__20250813_zN9BJv1PEcF5" style="font-size: 18pt"><b><ix:nonNumeric contextRef="AsOf2025-08-13" id="Fact000011" name="dei:EntityRegistrantName">Aethlon
Medical, Inc.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its
charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 39%; font-size: 10pt; text-align: center"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20250813__20250813_zIEmPxfY5iEe"><ix:nonNumeric contextRef="AsOf2025-08-13" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 22%; font-size: 10pt; text-align: center"><b><span id="xdx_903_edei--EntityFileNumber_c20250813__20250813_zCzefo7OI8l4"><ix:nonNumeric contextRef="AsOf2025-08-13" id="Fact000013" name="dei:EntityFileNumber">001-37487</ix:nonNumeric></span></b></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 39%; font-size: 10pt; text-align: center"><b><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20250813__20250813_z7Xm3bIFmVO9"><ix:nonNumeric contextRef="AsOf2025-08-13" id="Fact000014" name="dei:EntityTaxIdentificationNumber">13-3632859</ix:nonNumeric></span></b></td></tr>
  <tr>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction of
    incorporation)</p></td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission File Number)</p></td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(IRS Employer Identification No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 50%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_905_edei--EntityAddressAddressLine1_c20250813__20250813_zBKPEfmmOge2"><ix:nonNumeric contextRef="AsOf2025-08-13" id="Fact000015" name="dei:EntityAddressAddressLine1">11555
    Sorrento Valley Road</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressAddressLine2_c20250813__20250813_zcIlqfIZOHq4"><ix:nonNumeric contextRef="AsOf2025-08-13" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite
    203</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90D_edei--EntityAddressCityOrTown_c20250813__20250813_zC1LvNNdzUwd"><ix:nonNumeric contextRef="AsOf2025-08-13" id="Fact000017" name="dei:EntityAddressCityOrTown">San Diego</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressStateOrProvince_c20250813__20250813_zC3oJEaDh75b"><ix:nonNumeric contextRef="AsOf2025-08-13" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span></b></p></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center; width: 50%"><b><span id="xdx_902_edei--EntityAddressPostalZipCode_c20250813__20250813_z3Cu77z7qJtc"><ix:nonNumeric contextRef="AsOf2025-08-13" id="Fact000019" name="dei:EntityAddressPostalZipCode">92121</ix:nonNumeric></span></b></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center">(Address of principal executive offices)</td>
    <td style="vertical-align: top; text-align: center">(Zip Code)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code: <b>(<span id="xdx_90B_edei--CityAreaCode_c20250813__20250813_z07xtufC70Ck"><ix:nonNumeric contextRef="AsOf2025-08-13" id="Fact000020" name="dei:CityAreaCode">619</ix:nonNumeric></span>)</b><b> <span id="xdx_909_edei--LocalPhoneNumber_c20250813__20250813_zAYTLJ6dpsml"><ix:nonNumeric contextRef="AsOf2025-08-13" id="Fact000021" name="dei:LocalPhoneNumber">941-0360</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_edei--WrittenCommunications_c20250813__20250813_zcYmX8Nh3mUf"><ix:nonNumeric contextRef="AsOf2025-08-13" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_edei--SolicitingMaterial_c20250813__20250813_z0dlk6riMyS5"><ix:nonNumeric contextRef="AsOf2025-08-13" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_edei--PreCommencementTenderOffer_c20250813__20250813_zOxvFClb6zZ2"><ix:nonNumeric contextRef="AsOf2025-08-13" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20250813__20250813_zLCyJPyXf7n9"><ix:nonNumeric contextRef="AsOf2025-08-13" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 33%; text-align: center">Title of each class</td>
    <td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Trading Symbol(s)</p></td>
    <td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 33%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Name of each exchange on which registered</p></td></tr>
  <tr>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_900_edei--Security12bTitle_c20250813__20250813_z1XCJrIp84Ij"><ix:nonNumeric contextRef="AsOf2025-08-13" id="Fact000026" name="dei:Security12bTitle">Common Stock, $0.001 par value per share</ix:nonNumeric></span></b></p></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><b><span id="xdx_90C_edei--TradingSymbol_c20250813__20250813_zUHSo6oOVqz9"><ix:nonNumeric contextRef="AsOf2025-08-13" id="Fact000027" name="dei:TradingSymbol">AEMD</ix:nonNumeric></span></b></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><b>The <span id="xdx_90E_edei--SecurityExchangeName_c20250813__20250813_z2ufG4TKKraj"><ix:nonNumeric contextRef="AsOf2025-08-13" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167; 240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20250813__20250813_zATOA95Oxej6"><ix:nonNumeric contextRef="AsOf2025-08-13" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 2.02 Results of Operations and Financial Condition.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information provided below in &#8220;Item 7.01 - Regulation FD
Disclosure&#8221; of this Current Report on Form 8-K (this &#8220;Current Report&#8221;) is incorporated by reference into this Item 2.02.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b>Item
7.01 Regulation FD Disclosure.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On August 13, 2025, Aethlon
Medical, Inc. (the &#8220;Company&#8221;) issued a press release regarding its financial results for the quarter ended June 30, 2025.
A copy of that press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The information set forth
under Item 7.01 of this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed &#8220;filed&#8221;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to
the liabilities of such section. The information in Item 7.01 of this Current Report, including Exhibit 99.1, shall not be incorporated
by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference
language in any such filing, except as expressly set forth by specific reference in such a filing. This Current Report will not be deemed
an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 9.01 Financial
Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; background-color: white"><b>(d) Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; text-align: center; vertical-align: top; width: 72px"><span style="font-size: 10pt"><b>Exhibit Number</b></span></td>
    <td style="vertical-align: top; width: 14px">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="aethlon_ex9901.htm">Press Release, dated August 13, 2025.</a></span></td></tr>
  <tr>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">104</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the inline XBRL Document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">Date: August 13, 2025</span></td>
    <td colspan="2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>AETHLON MEDICAL, INC.</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 52%">&#160;</td>
    <td style="width: 4%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; width: 44%"><span style="font-size: 10pt"><i>/s/ James B. Frakes</i></span></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td>
    <td style="vertical-align: bottom">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">James B. Frakes</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Executive Officer and Chief Financial Officer</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>





<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2OUyX6sHHpCKyEInodckxlnRHZrfST+ovW5VouDAM9565QszEjra6RobrusjgjE1bK4dQYIWM5oY+ke4PCfhd4F1bx8q48fyBKXkGPbMMpVTeGKMvbbFMIFrM5SCIVkkcQ34UweCnZCpdonFa1aBMCTlTyxqd4n76cFYdGWr6seqCbDWZBOIwmuwPyCiWcKKXehM/LGRZKoLZOIHYMT1bn9p0Ds1AwqbGxtfZif4r+AIFFUqK -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>aethlon_ex9901.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><IMG SRC="image_001.jpg" ALT="" STYLE="height: 54.75pt; width: 144.75pt"></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>Aethlon Medical
Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Australian Cancer Trial Advances with First Cohort
Complete, Amended Protocol, and Promising Preclinical Data Published; Operating Expenses Cut by 32%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Conference Call to be Held Today at 4:30 p.m.
ET</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SAN DIEGO, August 13, 2025 -- Aethlon Medical,
Inc. (the Company or Aethlon) (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening
infectious diseases, today reported financial results for its fiscal first quarter ended June 30, 2025, and provided an update on recent
developments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #262626"><B>Key First Quarter Highlights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #262626">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Symbol">&middot;</FONT> <B>First Cohort Complete</B>
in Australian Hemopurifier&reg; cancer trial &mdash; all patients treated without device-related serious adverse events and no dose-limiting
toxicities observed</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Symbol">&middot;</FONT> <B>Amended Protocol</B>
broadens patient eligibility to allow all treatment regimens that include an anti-PD-1 agent</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Symbol">&middot;</FONT> <B>Preclinical Data</B>:
98.5% removal of platelet-derived extracellular vesicles (EVs) in simulated 4-hour treatment</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Symbol">&middot;</FONT> <B>Long COVID Pre-Clinical
Research</B> collaboration with UCSF advances, with findings presented at the prestigious Keystone Symposium</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Symbol">&middot;</FONT> <B>Operating Expenses
Reduced by 31.6%</B>, enhancing operational efficiency</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #0D0D0D"><B>Clinical Progress in Cancer
Trial</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #0D0D0D"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ongoing progress continues in the Australian Oncology
trial evaluating the Hemopurifier in participants with solid tumors that have not responded to anti-PD-1 immunotherapy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aethlon successfully completed the first treatment
cohort in its safety, feasibility, and dose-finding study. This initial cohort involved single Hemopurifier treatments for participants
with tumors unresponsive to PD-1 inhibitors such as pembrolizumab (Keytruda&reg;) or nivolumab (Opdivo&reg;). Treatments were completed
at Royal Adelaide Hospital and Royal North Shore Hospital between late January and June 2025. All participants tolerated the 4-hour Hemopurifier
treatment without device-related deficiencies or immediate complications, and no dose-limiting toxicities or device-related serious adverse
events were observed at the pre-specified 7-day safety follow-up. One participant subsequently died from disease progression, unrelated
to the Hemopurifier treatment, and was only able to complete one week of follow-up.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 11, 2025, the independent Data Safety
Monitoring Board (DSMB) convened to review the safety data from the three participants in this first cohort. Following closed-session
deliberations, the DSMB recommended advancing to the second treatment cohort, in which participants will receive two Hemopurifier treatments
within a one-week period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All three clinical sites in Australia are actively
screening patients for the cohort two under an amended protocol. The amendment expands eligibility to patients receiving either monotherapy
or combination therapy that includes Pembrolizumab or Nivolumab, better reflecting current standards of care and broadening the potential
patient pool.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Meanwhile, Professor Georges Grau&rsquo;s laboratory
at the University of Sydney continues to analyze central lab samples from the first patient cohort to assess the effects of the Hemopurifier
on extracellular vesicle counts and anti-tumor T cell activity. Initial observations from this analysis are expected in September 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a reminder, the primary endpoint of the approximate
9 to 18-participant trial is safety. Eligible patients with solid tumors with stable or progressive disease receive escalating doses of
Hemopurifier treatment across sequential cohorts - one, two, and three Hemopurifier treatments administered over the course of a single
week. In addition to evaluating safety, the study is designed to assess whether reducing the concentration of extracellular vesicles (EVs)
may improve the body&rsquo;s own natural ability to attack tumor cells. These exploratory findings are expected to inform the design of
future efficacy and safety trials, including a Premarket Approval (PMA) study.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe the unmet need remains significant:
currently, only approximately 30-40% of patients who receive pembrolizumab or nivolumab will have lasting clinical responses to these
agents. EVs produced by tumors are believed to contribute to both cancer progression and resistance to anti-PD-1 therapies. The Hemopurifier,
designed to selectively bind and remove EVs from the bloodstream, has demonstrated EV reduction in preclinical studies using plasma from
cancer patients, and may improve therapeutic response rates to anti-PD-1 antibodies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #0D0D0D"><B>India Update</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #0D0D0D"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While the Company received formal approval from
India&rsquo;s Central Drugs Standard Control Organization (CDSCO) to initiate a similar oncology trial at Medanta Medicity Hospital, subsequent
timeline discussions with our India-based CRO indicated the first patient treatment would likely not occur until the beginning of 2026.
Given this extended timeline and with careful consideration of both projected costs and our broader strategic priorities, we made the
decision not to proceed with the India study. We believe this allows us to focus our resources on advancing our ongoing trial in Australia,
which remains better aligned with our goal of generating timely clinical data to support a potential PMA trial.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #0D0D0D"><B>Preclinical Study Supports
Broader Applications</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #0D0D0D"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 12, 2025, results from Aethlon&rsquo;s
preclinical ex vivo study were published in <I>bioRxiv</I>, with a manuscript now under review at a peer-reviewed journal. The study showed
that the Hemopurifier, utilizing Aethlon&rsquo;s proprietary <I>Galanthus nivalis agglutin</I> (GNA) affinity resin, removed 98.5% of
platelet -derived extracellular vesicles (PD-EVs) from healthy human plasma during a timepoint equivalent to a 4-hour HP treatment. Excessive
levels of PD-EVs have been associated with a wide range of conditions, including cancer, lupus, systemic sclerosis, multiple sclerosis,
Alzheimer&rsquo;s disease, sepsis, and acute and Long COVID. We believe these findings support the scientific rationale behind Aethlon&rsquo;s
ongoing oncology trial in Australia and suggest broader potential applications of the Hemopurifier in other EV-associated diseases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #0D0D0D"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #0D0D0D"><B>Scientific Collaboration in
Long COVID Research</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 12th, 2025, Aethlon presented a poster
at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes held in Santa Fe, New Mexico. Long COVID, characterized
by persistent symptoms following acute COVID-19 infection, affect approximately 44 and 48 million people in the United States alone with
an estimated economic burden of 2 billion dollars among those with symptoms lasting a year. Despite the scope of this public health challenge,
no specific treatments are currently available, highlighting a significant unmet medical need.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">EVs have been implicated in the pathogenesis of
Long COVID. Building on prior evidence that the Aethlon Hemopurifier can remove EVs in a patient with severe acute COVID-19 infection,
the Company hypothesized EVs from individuals with Long COVID may also express surface mannose sugar that binds to its proprietary GNA.
Aethlon partnered with investigators at the University of California San Francisco Medical Center Long COVID clinic to obtain samples
from participants with Long COVID as well recovered COVID -19 participants as controls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The data presented at the symposium demonstrated
that both large and small EVs from Long COVID patients bound to the GNA lectin and the Hemopurifier&rsquo;s lectin affinity resin, supporting
the potential utility of the device in affected individuals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The full poster will soon be available for public
viewing on the Aethlon Medical website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operational Achievements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&ldquo;In
the first quarter, we advanced our lead oncology program, delivered preclinical results supporting broader applications including Long
COVID &mdash; all while significantly reducing operating expenses,&rdquo;</B></FONT> said James Frakes, Chief Executive Officer of Aethlon
Medical. <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&ldquo;We remain committed to driving the Hemopurifier toward regulatory
approval and unlocking its potential across multiple disease areas.&rdquo;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial Results for the Fiscal First Quarter
Ended June 30, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of June 30, 2025, Aethlon had a cash balance
of approximately $3.8 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended June 30, 2025, consolidated
operating expenses were approximately $1.8 million, representing a decrease of approximately $800,000 or approximately 31.6%, compared
to approximately $2.6 million for the same period in 2024. This reduction was primarily driven by lower payroll and related expenses,
professional fees, and general and administrative costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payroll and related expenses declined by approximately
$674,000, largely due to the absence of a $321,000 in severance expense recorded in the prior-year quarter related to the separation of
an executive. In addition, the Company realized a $286,000 reduction in compensation costs as a result of lower headcount, as well as
a $67,000 decrease in stock-based compensation tied to the same reduction in the workforce.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Professional fees decreased by an approximate
$138,000, primarily due to a $104,000 reduction in legal fees following the transition to a new legal firm, a $34,000 decrease in scientific
consulting costs after the conclusion of a project, a $23,000 reduction in audit-related fees. Additionally contract labor costs decreased
by $18,000 due to the completion of a regulatory project and shift to lower-cost quality management system consultants. These reductions
were partially offset by a $42,000 increase in investor relations expenses related to the special meeting of stockholders held during
the quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">General and administrative expenses declined by
an approximate $17,000, primarily driven by a $31,000 reduction in insurance costs, partially offset by a $26,000 increase in clinical
trial-related expenses. Other variances included a mix of increases and decreases across multiple categories, none of which were individually
significant, resulting in an overall decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the above factors, operating loss
for the quarter decreased to $1.8 million compared to $2.6 million for the three months ended June 30, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Other Income </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other income totaled $30,532 for the three months
ended June 30, 2025, compared to $49,418 in the prior-year period. In both quarters, other income was primarily interest income earned
on cash balances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated balance sheets for June 30, 2025
and March 31, 2025, along with the consolidated statements of operations for the three months ended June 30, 2025 and 2024, are included
at the end of this release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Conference Call</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management will host a conference call today,
Wednesday, August 13, 2025, at 4:30 p.m. ET to review the company&rsquo;s financial results and recent corporate developments. Following
management&rsquo;s formal remarks, there will be a question and answer session.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Interested parties can register for the conference
call by navigating to https://dpregister.com/sreg/10201884/ffac7acee8. Please note that registered participants will receive their dial-in
number upon registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Interested parties without internet access or
unable to pre-register may dial in by calling:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PARTICIPANT DIAL IN (TOLL-FREE): 1-844-836-8741</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">PARTICIPANT INTERNATIONAL DIAL IN: 1-412-317-5442</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All callers should ask for the Aethlon Medical,
Inc. conference call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A replay of the call will be available approximately
one hour after the end of the call through September 13, 2025. The replay can be accessed via Aethlon Medical&rsquo;s website or by dialing
1-877-344-7529 (domestic) or 1-412-317-0088 (international) or Canada toll-free at 1-855-669-9658. The replay conference ID number is
1454680.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">About the Hemopurifier&reg;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Aethlon Hemopurifier is an investigational
medical device designed to remove enveloped viruses and tumor-derived extracellular vesicles (EVs) from circulation. It is used extracorporeally
with a blood pump and combines plasma separation, size exclusion, and affinity binding using a plant lectin resin that targets mannose-rich
surfaces found on EVs and viruses. EVs released by solid tumors are believed to play a role in metastasis and the resistance to immunotherapies
and chemotherapy. Removal of enveloped viruses and extracellular vesicles has been demonstrated in both vitro studies and human subjects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Hemopurifier holds a U.S. Food and Drug Breakthrough
Device Designation for:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The treatment of individuals with advanced or
metastatic cancer unresponsive to or intolerant of standard-of-care therapy; and the treatment of life-threatening viruses not addressed
with approved therapies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">About Aethlon Medical, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aethlon Medical, Inc. (Nasdaq: AEMD) is a clinical-stage
medical device company headquartered in San Diego, California. Aethlon is advancing the Hemopurifier, to address unmet needs in oncology
and infectious disease, using a novel platform designed to selectively remove circulation pathogenic targets from biologic fluids.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more information, visit www.AethlonMedical.com
and follow the Company on LinkedIn.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This press release contains forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that
involve risks and uncertainties. Statements containing words such as &quot;may,&quot; &quot;believe,&quot; &quot;anticipate,&quot; &quot;expect,&quot;
&quot;intend,&quot; &quot;plan,&quot; &quot;project,&quot; &quot;will,&quot; &quot;projections,&quot; &quot;estimate,&quot; &quot;potentially&quot;
or similar expressions constitute forward-looking statements. Such forward-looking statements are subject to significant risks and uncertainties
and actual results may differ materially from the results anticipated in the forward-looking statements. These forward-looking statements
are based upon Aethlon's current expectations and involve assumptions that may never materialize or may prove to be incorrect. Factors
that may contribute to such differences include, without limitation, the Company's ability to raise additional capital on terms favorable
to the Company, or at all; the Company&rsquo;s ability to successfully complete development of the Hemopurifier; the Company&rsquo;s ability
to successfully demonstrate the utility and safety of the Hemopurifier in cancer and infectious diseases and in the transplant setting;
the Company&rsquo;s ability to achieve and realize the anticipated benefits from operational and financial milestones; the Company&rsquo;s
ability to obtain approval from the Ethics Committee of its third location in Australia, including on the timeline expected by the Company;
the Company&rsquo;s ability to enroll additional patients in its oncology clinical trial in Australia, including on the timeline expected
by the Company; the Company&rsquo;s ability to manage and successfully complete its clinical trials; the Company&rsquo;s ability to successfully
manufacture the Hemopurifier in sufficient quantities for its clinical trials; unforeseen changes in regulatory requirements; the Company&rsquo;s
collaborative research with UCSF Long Covid Clinic; and the Company&rsquo;s ability to further research potential applications of the
Hemopurifier in other EV-associated diseases and other potential risks. The foregoing list of risks and uncertainties is illustrative
but is not exhaustive. Additional factors that could cause results to differ materially from those anticipated in forward-looking statements
can be found under the caption &quot;Risk Factors&quot; in the Company's Annual Report on Form 10-K for the year ended March 31, 2025,
and in the Company's other filings with the Securities and Exchange Commission, including its quarterly Reports on Form 10-Q. All forward-looking
statements contained in this press release speak only as of the date on which they were made. Except as may be required by law, the Company
does not intend, nor does it undertake any duty, to update this information to reflect future events or circumstances.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Company Contact:</B><BR>
Jim Frakes<BR>
Chief Executive Officer and Chief Financial Officer<BR>
Aethlon Medical, Inc.<BR>
Jfrakes@aethlonmedical.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Contact:</B><BR>
Susan Noonan<BR>
S.A. Noonan Communications, LLC<BR>
susan@sanoonan.com<BR></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">AETHLON MEDICAL, INC. AND SUBSIDIARY</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Condensed Consolidated Balance Sheets</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Unaudited</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">June 30, 2025</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">March 31, 2025</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: center">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">CURRENT ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 66%; text-align: left; padding-left: 10pt">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">3,765,154</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">5,501,261</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Deferred offering costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,103</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">276,601</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">448,539</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">TOTAL CURRENT ASSETS</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,050,858</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,949,800</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">593,720</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">676,220</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Operating lease right-of-use asset</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">529,576</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">601,846</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Patents, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">413</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">550</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Restricted cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">98,130</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">97,813</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 1pt; padding-left: 10pt">Deposits</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">33,305</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">33,305</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">TOTAL ASSETS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,306,002</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,359,534</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center">LIABILITIES AND STOCKHOLDERS' EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">CURRENT LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">571,495</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">534,524</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Due to related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">372,598</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">579,565</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Operating lease liability, current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">318,800</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">313,033</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">364,544</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">472,164</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">TOTAL CURRENT LIABILITIES</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,627,437</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,899,286</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Operating lease liability, less current portion</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">255,052</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">336,718</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">TOTAL LIABILITIES</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,882,489</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,236,004</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">STOCKHOLDERS' EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt">Common stock, $0.001 par value; 60,000,000 shares authorized as of June 30, 2025 and March 31, 2025; 2,598,711 and 2,585,239 shares issued and 2,598,711 and 2,010,739 outstanding as of June 30, 2025 and March 31, 2025, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,599</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,586</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">173,159,966</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">173,092,894</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accumulated other comprehensive loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(22,377</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(17,133</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(169,716,675</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(167,954,817</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">TOTAL STOCKHOLDERS' EQUITY</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,423,513</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,123,530</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,306,002</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,359,534</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">AETHLON MEDICAL, INC. AND SUBSIDIARY</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Condensed Consolidated Statements of Operations and Comprehensive Loss</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">For the three months ended June 30, 2025 and 2024</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Unaudited</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Three Months</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Three Months</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Ended 6/30/25</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Ended 6/30/24</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">OPERATING EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 66%; text-align: left; padding-left: 10pt">Professional fees</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">476,032</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">614,082</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Payroll and related expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">581,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,254,802</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">General and administrative</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">735,358</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">751,974</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,792,390</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,620,858</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">OPERATING LOSS</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,792,390</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,620,858</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">OTHER (EXPENSE) INCOME, NET</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,466</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,418</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(5,934</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Total other expense (income)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">30,532</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">49,418</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">NET LOSS</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,761,858</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,571,440</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">NET LOSS ATTRIBUTABLE TO AETHLON MEDICAL, INC.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,761,858</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,571,440</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">OTHER COMPREHENSIVE LOSS</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(5,244</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(833</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">COMPREHENSIVE LOSS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1,767,102</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2,572,273</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per share attributable to common stockholders</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.85</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2.76</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares outstanding - basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,076,416</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">932,248</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>aemd-20250813.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOa2LiaPty552eYkxvmR5fbm6DykogJHwkS/jJgwm8bQC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:AEMD="http://aethlonmedical.com/20250813" elementFormDefault="qualified" targetNamespace="http://aethlonmedical.com/20250813">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://aethlonmedical.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="aemd-20250813_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="aemd-20250813_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>aemd-20250813_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>aemd-20250813_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="aemd-20250813.xsd#Cover" roleURI="http://aethlonmedical.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://aethlonmedical.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH CYI:9(PC4L3@5\3?M.?MH-H,UUX7\"7"S:@I\J]UI#OCMO\
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MZ--=Z')XF\0ZS*_V'1X;O[,#%&5,TKS;'V*-RX&T[B?9BOC_ ,6-6\)?MC?
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MY=H9=F-OSLK_ #_=;8C@'Z"T44C?=- 'YQ?\%"O&#:M\5M*T.-\P:3IV]O\
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M;]WW=Y==Q9'K[*H JV]O%:0K#$BQ0HNU$5<*JU_-3^T9_P G!?$[_L9]4_\
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MPK]J*_%?_@BS_P G3>*/^Q,NO_2VPK]J* &K7C'[:/\ R:7\7O\ L5[_ /\
M1+5[.M>,?MH_\FE_%[_L5[__ -$M0)GX?_L&_P#)X7PE_P"PY#_)J_HIK^=;
M]@W_ )/"^$O_ &'(?Y-7]%- S^?#_@I)_P GM_%'_K[MO_2."OV*_P""?O\
MR9K\*?\ L$C_ -&/7XZ_\%)/^3V_BC_U]VW_ *1P5^Q7_!/W_DS7X4_]@D?^
MC'H _.C_ (+0>%[O3_VBO">NF!EL-3\-) DW]^:&YG\Q?P26'_ONOJC_ ((^
M^-$\0?LNW^A/,OVOP_K]S!Y._+I#,B3(^W^$%WF'_ &KK_\ @I-^S+<?M$?
MO[=H5HU[XP\)R2:CI\$,9DEN867_ $FV51_$RHCJ.2SPHG\5?F/^P/\ M;?\
M,I_%2:ZU<33>"=?BCM-9M[=-SQ[#F&Y1?XFCWR97NDC]6VT ?O[17%?#OXE>
M&/BQX;MO$'A'7+/Q#I$Z_)>:?+O3/&4;^XXXRC89<UM:YKFF^&]'O-4U?4;7
M2M+M8FFN+V^F2*&%.[.[':J_6@#R7]M[Q59>"_V1_BWJ%^V(9O#MYIBX_P">
MMVGV:+_Q^9*_%+]@7P?_ ,)U^V-\*M//"P:NFI_^ B-<_P#M&OHC_@II^W%I
MGQPO(OAIX!O%O_"&DW7VG4=8A;]WJ5TN41(?[\,>X_/_ !O\R_(B._KG_!(/
M]F^^\.Z;JWQCURVEMFU2W.F:%%)T>VWAYKC9_MNB(AS_  2_WEH _0WXP?\
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M'P9T/PIX/GTRWU&S\00ZG(VK7+PQ^4EM<Q$ HCY;=,O;M7U;10!^='_!/?\
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MGQT\0:EXP\$7<?@_QA?.9KNVF3=I=_,-^7=4^>%W8IO=-V<9\O>[O7WKD4M
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M4 %%%% !1110!&O>OF3]NCP+KWCKX<Z'9^'=(NM9NH]729H;./>Z+Y,P+_\
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MGR[X=_:"^*GBJ/6KB?X47^C6EGI\LUNLT4SS7-U\B11IN1/XG.[Y.%1C7/\
M[%_P/U[0=6\2^,O&^ESVVMWDOV>!-2B'G?-AYIO^!OL_[X:OL-8QT(%*JC:1
MBD\4XPE&"4>:PU@N:<9U9<W*>#?M8?!]?B9\);ZSTRT6?6+&1;ZSCC4!Y'3[
MZ=/XD9_^!%:^<?$W@GXD>+/V4_#_ (5O?">K?VQHNO(D,+P-O>T\F;9)_P
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ I&QWI:* .'\:?"_PM\0(1!XA\/V&
MK(@^1[JW5W3_ '&^\OX5X/XL_P""??@/6)&ETBZU30G_ ((8;CSX5_!_G_\
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>EZGI4L/1H_PX6):***Q.L**** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 13, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 13,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Aethlon
Medical, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000882291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3632859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">11555
    Sorrento Valley Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite
    203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">941-0360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AEMD<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="aemd_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aethlonmedical.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>aemd-20250813.xsd</File>
    <File>aemd-20250813_lab.xml</File>
    <File>aemd-20250813_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="aemd_8k.htm">aemd_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "aemd_8k.htm": {
   "nsprefix": "AEMD",
   "nsuri": "http://aethlonmedical.com/20250813",
   "dts": {
    "schema": {
     "local": [
      "aemd-20250813.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "aemd-20250813_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aemd-20250813_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "aemd_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://aethlonmedical.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-08-13",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aemd_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-08-13",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aemd_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://aethlonmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001683168-25-006042-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-25-006042-xbrl.zip
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MU75U576W?/R?R5@CC\RR54,_^4/(YO\@3)<-1=6')W_4>XU.YX__U%+'(P?
M %2W3](CQS&KN=S3TU/VJ9 UK&%.J%0JN0G"I#V@ZB063LSGA=S-Q7E/'K$Q
MS:BZ[5!=9K.'-%6_3\:/HS-0R=+4""A^$Q IY)90PZ@R?R ,?)#S!B.@3BQH
MR0-U E#5-HJB4'Z.#P]B]L D"59 GF&&[.;T^GP.[L3#ST%SCD5U>V!88^J
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MRD=56&(H";=D*%-B.U.-G:0'8'E5(N1-A_35,4!<LB=R;8RION]]L0_T+76
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MG/L SWQL\2DPE81G@I$%EL+4@^]\\45$ZNJJ)T]PKD4ACAFU78O5?">L DB
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M&DBTYQCR_3[Y5SZ;SPO$I!9YI)K+B(GW-O!8_&OV*9ZSK95[X#'2:_C2\YW
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M'1_Y_6Q4@$\ZA"H7X,+A))X6JUA+'8Z<Z$0PT0FR'/]2Z**R)8O1^XS$((H
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M\)E:.GSQ>1]M@XX]^PH;<A@XL.;]V669)Z@0B.U*=T /TJ84/JBID+UH'BG
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M'XAH).&3$+X+/X(P$O^)S0#F$AW/EK;X+?:DJ)8,42E5ZH8P/5M<!/ZU8\.
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MOWZJJ[/28P@WGL3P03@%$VD,G#.$38'EY<"S,:", Z9_YED^UW;_&4G81I#
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M_P-02P$"% ,4    " #P@0U;G\H4+BP#  #T"P  $0              @ $
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;,2YH=&U02P4&      4 !0 ^ 0  WE

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>aemd_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="aemd-20250813.xsd" xlink:type="simple"/>
    <context id="AsOf2025-08-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000882291</identifier>
        </entity>
        <period>
            <startDate>2025-08-13</startDate>
            <endDate>2025-08-13</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-08-13" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-08-13" id="Fact000004">0000882291</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-08-13" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-08-13" id="Fact000010">2025-08-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-08-13" id="Fact000011">Aethlon Medical, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-08-13" id="Fact000012">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-08-13" id="Fact000013">001-37487</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-08-13" id="Fact000014">13-3632859</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-08-13" id="Fact000015">11555     Sorrento Valley Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-08-13" id="Fact000016">Suite     203</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-08-13" id="Fact000017">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-08-13" id="Fact000018">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-08-13" id="Fact000019">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-08-13" id="Fact000020">619</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-08-13" id="Fact000021">941-0360</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-08-13" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-08-13" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-08-13" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-08-13" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-08-13" id="Fact000026">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-08-13" id="Fact000027">AEMD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-08-13" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-08-13" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
